PROPANC HEALTH GROUP CORP

Inactive Instrument

Insiders Propanc Health Group Corp Other OTC

Equities

US74345C1027

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-15	Propanc Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
04-16	Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Carlo Campiciano Resigns as Chief Financial Officer of Propanc Biopharma, Inc	20-12-30	CI
Propanc Biopharma, Inc. Announces Executive Changes	20-12-30	CI
Propanc Biopharma, Inc. and Propanc Pty Ltd Announce Management Appointments, Effective July 1, 2019	19-07-01	CI
Propanc Biopharma Appoints Ralf Brandt to Scientific Advisory Board	19-05-06	CI
Propanc Biopharma Inc. Announces the Engagement of Mr. Alan Morell as A Senior Strategic Advisor for the Company	18-01-10	CI
Propanc Health Group Corporation will Change its Name to Propanc Biopharma Inc	17-04-07	CI
Propanc Health Group Corporation Announces the Resignation of Douglas Mitchell as President and Chairman of Board of Director of Company	12-08-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer